Daré Bioscience presents sildenafil cream study at Menopause Society annual meeting
DARE•Daré Bioscience will attend The Menopause Society’s annual meeting Oct. 20-24, 2026, and present on its Phase 1 Sildenafil Cream, 3.6% program.
1. Meeting plans
Daré Bioscience will attend The Menopause Society’s annual meeting in San Diego from Oct. 20-24, 2026, with a presentation on its Phase 1 Sildenafil Cream, 3.6% program.
2. Program sponsorship
The company will sponsor HERmedicine’s Managing Menopause After Breast Cancer program on Oct. 20, 2026.
